Michael J. Kuhar

Q: What Schools Are Affiliated With Michael J. Kuhar

Michael J. Kuhar is affiliated with the following schools: Emory University, Yale University, Drew University, Johns Hopkins University, Karolinska Institute, Harvard University, University of Scranton

Michael J. Kuhar's AcademicInfluence.com Rankings

Michael J. Kuhar

Biology

#2276

World Rank

#3637

Historical Rank

#1021

USA Rank

Neuroscience

#188

World Rank

#199

Historical Rank

#80

USA Rank

biology Degrees

Download Badge

Biology

Why Is Michael J. Kuhar Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Michael J. Kuhar , is an American neuroscientist, author, and Candler Professor of Neuropharmacology at The Yerkes National Primate Research Center of Emory University. He is a Georgia Research Alliance eminent scholar, and a senior fellow in the Center for Ethics at Emory. He was previously a professor at Johns Hopkins University School of Medicine and branchchief at the National Institute on Drug Abuse.

(See a Problem?)

Michael J. Kuhar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cocaine receptors on dopamine transporters are related to self-administration of cocaine. (1987) (2194)
Neurotransmitter transporters: recent progress. (1993) (1093)
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. (1986) (922)
The dopamine hypothesis of the reinforcing properties of cocaine (1991) (919)
Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla (1977) (865)
Leptin Activates Hypothalamic CART Neurons Projecting to the Spinal Cord (1998) (796)
A new method for receptor autoradiography: [3H]Opioid receptors in rat brain (1979) (783)
Regional Distribution of Opiate Receptor Binding in Monkey and Human Brain (1973) (775)
EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN (1984) (709)
Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents (1984) (708)
Autoradiographic localization of opiate receptors in rat brain. II. The brain stem (1977) (601)
Opiate receptor: autoradiographic localization in rat brain. (1976) (587)
Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system. (1977) (580)
Imaging dopamine receptors in the human brain by positron tomography (1983) (554)
Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon (1977) (550)
Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. (1991) (544)
Quantitative receptor autoradiography using [3H]Ultrofilm: application to multiple benzodiazepine receptors (1982) (513)
In situ injection of kainic acid: A new method for selectively lesioning neuronal cell bodies while sparing axons of passage (1978) (475)
Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. (1990) (474)
Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study (1985) (473)
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987) (463)
Cocaine‐ and amphetamine‐regulated transcript peptide immunohistochemical localization in the rat brain (1998) (435)
Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. (1980) (409)
Characterization of CART neurons in the rat and human hypothalamus (2001) (396)
Immunohistochemical mapping of enkephalin containing cell bodies, fibers and nerve terminals in the brain stem of the rat (1979) (390)
CART peptides in the central control of feeding and interactions with neuropeptide Y (1998) (386)
Neurotransmitter Receptor Binding (1984) (383)
Immunohistochemical Localization of Novel CART Peptides in Rat Hypothalamus, Pituitary and Adrenal Gland (1997) (377)
Autoradiographic localization of the opiate receptor in rat brain (1975) (375)
SODIUM‐DEPENDENT, HIGH AFFINITY CHOLINE UPTAKE (1978) (359)
Neurotensin: immunohistochemical localization in rat central nervous system. (1977) (333)
High affinity GABA receptors — Autoradiographic localization (1981) (305)
Protein Kinase C-mediated Phosphorylation and Functional Regulation of Dopamine Transporters in Striatal Synaptosomes* (1997) (304)
The distribution of histamine H1-receptors in the rat brain: An autoradiographic study (1981) (299)
CART peptides: regulators of body weight, reward and other functions (2008) (284)
Iontophoretic application of opiates to the locus coeruleus (1977) (282)
Neurotensin receptors are located on dopamine-containing neurones in rat midbrain (1981) (281)
Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo. (1975) (272)
The regional distribution of a morphine-like factor enkephalin in monkey brain (1976) (264)
Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease (1986) (263)
Immunohistochemical localization of enkephalin in rat forebrain (1980) (262)
Neurotensin receptor localization by light microscopic autoradiography in rat brain (1981) (262)
Further studies on the anatomical distribution of CART by in situ hybridization (1997) (261)
Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis. (1985) (255)
Autoradiographic localisation of benzodiazepine receptors in the brains of humans and animals (1979) (252)
Adenosine receptors: autoradiographic evidence for their location on axon terminals of excitatory neurons. (1983) (251)
Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. (1992) (248)
Imaging Opiate Receptors in the Human Brain by Positron Tomography (1985) (241)
The Dopamine Transporter: Comparative Ultrastructure of Dopaminergic Axons in Limbic and Motor Compartments of the Nucleus Accumbens (1997) (239)
Dopamine transporter immunoreactivity in rat brain (1995) (239)
Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: correlations with serotonin levels and histochemical fluorescence. (1972) (235)
Muscarinic cholinergic receptor binding: regional distribution in monkey brain (1974) (235)
Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. (1996) (231)
Localization of cholinergic muscarinic receptors in rat brain by light microscopic radioautography (1976) (219)
Receptor autoradiography with tritium-sensitive film: Potential for computerized densitometry (1981) (215)
Neurotransmitter uptake: a tool in identifying neurotransmitter-specific pathways. (1973) (205)
Quantitative receptor mapping by autoradiography: some current technical problems (1985) (204)
Serotonin-containing neuronal perikarya and terminals: differential effects of P-chlorophenylalanine. (1973) (202)
Imaging dopamine receptors in the human brain by positron tomography. (1984) (202)
Phorbol Esters Increase Dopamine Transporter Phosphorylation and Decrease Transport Vmax (1997) (201)
Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. (1999) (196)
Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo–pituitary axes in vitro and in vivo in male rats (2001) (196)
Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. (1984) (193)
Maternal separation alters drug intake patterns in adulthood in rats. (2007) (189)
Cocaine binding at σ receptors (1988) (188)
Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. (1972) (186)
Distribution and physiological significance of opioid receptors in the brain. (1983) (178)
Impulse-flow regulation of high affinity choline uptake in brain cholinergic nerve terminals (1975) (177)
Muscarinic cholinergic receptors: Autoradiographic localization of high and low affinity agonist binding sites (1980) (175)
Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. (2000) (175)
Nitric oxide inhibits [3H]dopamine uptake (1994) (175)
CART peptides: novel addiction- and feeding-related neuropeptides (1999) (173)
Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. (1989) (171)
SYNAPTOSOMAL TRANSPORT: A CHLORIDE DEPENDENCE FOR CHOLINE, GABA, GLYCINE AND SEVERAL OTHER COMPOUNDS (1978) (171)
In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428 (1993) (169)
Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity (1986) (167)
Presynaptic localization of opiate receptors in the vagal and accessory optic systems: An autoradiographic study (1978) (165)
Association of Cocaine- and Amphetamine-Regulated Transcript-Immunoreactive Elements with Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Its Role in the Regulation of the Hypothalamic–Pituitary–Thyroid Axis during Fasting (2000) (160)
In vivo identification of muscarinic cholinergic receptor binding in rat brain. (1974) (160)
Neurochemical changes in cocaine withdrawal. (1996) (160)
Neurotransmitter receptor mapping by autoradiography and other methods. (1986) (160)
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. (1971) (148)
Enkephalin-containing pathway: amygdaloid efferents in the stria terminalis (1978) (145)
Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptors (1983) (144)
Methods in Neurotransmitter Receptor Analysis (1990) (140)
Further evidence for cholinergic habenulo-interpeduncular neurons: Pharmacologic and functional characteristics (1975) (140)
Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter (1999) (139)
Ontogeny of muscarinic receptors in rat brain (1980) (138)
Beta adrenergic receptor localization in rat brain by light microscopic autoradiography (1982) (137)
Synthesis, ligand binding, QSAR, and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters. (1991) (135)
Cocaine and 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. (1995) (135)
Dopamine receptor binding in vivo: the feasibility of autoradiographic studies. (1978) (135)
Increased metabolism in the R6/2 mouse model of Huntington’s disease (2008) (134)
Cocaine- and amphetamine-regulated transcript in the rat vagus nerve: A putative mediator of cholecystokinin-induced satiety. (1999) (134)
CART in feeding and obesity (2004) (133)
[125I]RTI-55: a potent ligand for dopamine transporters. (1991) (127)
Ontogeny of GABA and benzodiazepine receptors: Effects of Triton X-100, bromide and muscimol (1979) (124)
Light autoradiographic localisation of cholinergic muscarinic receptors in rat brain by specific binding of a potent antagonist (1975) (123)
Cocaine‐ and amphetamine‐regulated transcript peptide projections in the ventral midbrain: Colocalization with γ‐aminobutyric acid, melanin‐concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons (2002) (122)
Preferential Increases in Nucleus Accumbens Dopamine after Systemic Cocaine Administration Are Caused by Unique Characteristics of Dopamine Neurotransmission (2000) (121)
The mismatch problem in receptor mapping studies (1985) (121)
Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. (1993) (121)
CART peptide analysis by Western blotting (1999) (121)
Sodium-dependent high affinity choline uptake. (1979) (118)
Quantification of Neuroreceptors in the Living Human Brain: IV. Effect of Aging and Elevations of D2-Like Receptors in Schizophrenia and Bipolar Illness (1997) (117)
Neuropeptide Y Innervation and Neuropeptide-Y-Y1-Receptor-Expressing Neurons in the Paraventricular Hypothalamic Nucleus of the Mouse (1999) (116)
Nitric oxide inhibits 3H‐glutamate transport in synaptosomes (1994) (115)
A unique synaptosomal fraction, which accumulates glutamic and aspartic acids, in brain tissue. (1971) (114)
CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight (2005) (114)
Cocaine inhibits muscarinic cholinergic receptors in heart and brain. (1988) (114)
Activation of high-affinity choline uptake in vitro by depolarizing agents. (1976) (112)
Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide (2005) (111)
Intra-Accumbal Injection of CART (Cocaine-Amphetamine Regulated Transcript) Peptide Reduces Cocaine-Induced Locomotor Activity (2003) (109)
Reductions in corticotropin releasing factor‐like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy (1987) (108)
Uptake and Subcellular Localization of Neurotransmitters in the Brain (1970) (108)
Noradrenergicα1 and α2 receptors: Autoradiographic visualization (1979) (108)
Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. (1989) (107)
Iontophoresis of methionine-enkephalin in the locus coeruleus area (1977) (107)
Cocaine‐ and amphetamine‐regulated transcript: distribution and function in rat gastrointestinal tract (2003) (106)
Cocaine and amphetamine regulated transcript (CART) and the stress response (2006) (106)
Release of acetylcholine from hippocampal slices by potassium depolarization: dependence on high affinity choline uptake. (1974) (105)
Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. (1988) (105)
Regional distribution of postsynaptic receptor binding for gamma-aminobutyric acid (GABA) in monkey brain (1975) (105)
Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4‐methylenedioxymethamphetamine): Assessment using quantitative autoradiography (1991) (103)
CART peptides (2000) (103)
Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. (1985) (103)
Iontophoresis of neurotensin in the area of the locus coeruleus (1978) (100)
Cocaine‐ and amphetamine‐regulated transcript (CART) peptide immunoreactivity in myenteric plexus neurons of the rat ileum and co‐localization with choline acetyltransferase (1998) (100)
Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra (1984) (99)
Immunogold Localization of the Dopamine Transporter: An Ultrastructural Study of the Rat Ventral Tegmental Area (1997) (99)
Striatal opiate receptors: pre- and postsynaptic localization. (1980) (99)
Receptors for neurotransmitters and peptide hormones. (1980) (98)
Ultrastructural localization of CART (cocaine‐ and amphetamine‐regulated transcript) peptides in the nucleus accumbens of monkeys (1997) (97)
Maternal separation alters serotonergic transporter densities and serotonergic 1A receptors in rat brain (2006) (94)
Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. (1994) (94)
Distribution of muscarinic cholinergic high and low affinity agonist binding sites: A light microscopic autoradiographic study (1984) (94)
Parkinson's disease: depletion of substantia nigra neurotensin receptors (1984) (93)
Cocaine- and Amphetamine-regulated Transcript (CART) Is Expressed in Several Islet Cell Types During Rat Development (2004) (93)
ON THE RELATIONSHIP BETWEEN [3H]CHOLINE UPTAKE ACTIVATION AND [3H]ACETYLCHOLINE RELEASE (1977) (93)
Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors (2005) (91)
Corticotropin-releasing factor receptors in rat pituitary gland: autoradiographic localization (1984) (91)
(3-N-[11C]methyl)spiperone, a ligand binding to dopamine receptors: radiochemical synthesis and biodistribution studies in mice. (1984) (90)
THE SUBCELLULAR LOCALIZATION OF HISTAMINE AND HISTAMINE METHYLTRANSFERASE IN RAT BRAIN 1 (1971) (89)
Developmentally regulated glycosylation of dopamine transporter. (1994) (89)
Neurotransmitter receptor alterations in Huntington's disease: Autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes (1985) (88)
In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine‐123 labeled RTI‐55 (1992) (87)
Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: Effects of lesions (1979) (87)
Cocaine binding at sigma receptors. (1988) (86)
Biochemical indentification of the mammalian muscarinic cholinergic receptor. (1975) (86)
Maternal Separation and Handling Affects Cocaine Self-Administration in Both the Treated Pups as Adults and the Dams (2006) (85)
Classical transmitters and transmitter receptors in the CNS (1984) (85)
Effects of early maternal separation on ethanol intake, GABA receptors and metabolizing enzymes in adult rats (2005) (85)
Radiohistochemical localization of insulin receptors in the adult and developing rat brain (1980) (85)
Muscarinic cholinergic receptors flow in the sciatic nerve (1981) (84)
Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency. (1992) (84)
3-Aryl-2-(3'-substituted-1',2',4'-oxadiazol-5'-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters. (1993) (83)
In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors. (1987) (83)
Species Differences in Dopamine Transporters: Postmortem Changes and Glycosylation Differences (1993) (83)
CART: from gene to function (1999) (79)
Dopamine transporter: biochemistry, pharmacology and imaging. (1990) (79)
Effects of electrical stimulation on acetylcholine levels in central cholinergic nerve terminals. (1974) (78)
[123/125I]RTI‐55, an in vivo label for the serotonin transporter (1992) (78)
Secondary amine analogues of 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. (1994) (78)
CART peptides (2002) (78)
Neuroleptic and dopamine receptors: Autoradiographic localization of [3H]spiperone in rat brain (1979) (78)
CART peptides are modulators of mesolimbic dopamine and psychostimulants. (2003) (76)
Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. (1992) (76)
POST‐MORTEM CHANGES IN HIGH AFFINITY CHOLINE UPTAKE (1979) (76)
D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons. (1975) (75)
Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. (1994) (75)
Anatomic localization of cholecystokinin receptors to the pyloric sphincter. (1984) (73)
CART peptides as targets for CNS drug development. (2003) (73)
[3H]cocaine binding and inhibition of [3H]dopamine uptake is similar in both the rat striatum and nucleus accumbens. (1989) (72)
CART regulates islet hormone secretion and is expressed in the beta-cells of type 2 diabetic rats. (2006) (71)
Choline and acetylcholine: regional distribution and effect of degeneration of cholinergic nerve terminals in the rat hippocampus. (1973) (69)
New, potent cocaine analogs: ligand binding and transport studies in rat striatum. (1990) (69)
Characterization of the cocaine‐ and amphetamine‐regulated transcript (CART) peptide gene promoter and its activation by a cyclic AMP‐dependent signaling pathway in GH3 cells (2002) (68)
Quantification and synthesis of cocaine- and amphetamine-regulated transcript peptide (79-102)-like immunoreactivity and mRNA in rat tissues. (2000) (67)
Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets (2005) (67)
N-modified analogues of cocaine: synthesis and inhibition of binding to the cocaine receptor. (1992) (67)
Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. (2001) (67)
μ Opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain (1989) (67)
In vivo binding of [125I] RTI‐55 to dopamine transporters: Pharmacology and regional distribution with autoradiography (1992) (67)
Mapping nicotinic acetylcholine receptors with PET (1996) (66)
Isopropyl and phenyl esters of 3 beta-(4-substituted phenyl)tropan-2 beta-carboxylic acids. Potent and selective compounds for the dopamine transporter. (1992) (65)
Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain (1996) (65)
Autoradiographic localization of drug and neurotransmitter receptors in the brain (1981) (65)
CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. (2008) (64)
Hypothalamic CART and serum leptin levels are reduced in the anorectic (anx/anx) mouse. (2000) (63)
Synthesis and ligand binding of cocaine isomers at the cocaine receptor. (1991) (63)
Corticotropin-releasing factor receptors in human pituitary gland: autoradiographic localization. (1985) (63)
Synthesis, ligand binding, and QSAR (CoMFA and classical) study of 3 beta-(3'-substituted phenyl)-, 3 beta-(4'-substituted phenyl)-, and 3 beta-(3',4'-disubstituted phenyl)tropane-2 beta-carboxylic acid methyl esters. (1994) (63)
Differential localization of type I and type II benzodiazepine binding sites in substantia nigra (1983) (62)
Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity. (1997) (62)
Cocaine‐induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non‐human primates (2005) (62)
Dopamine Transporter Ligand Binding Domains (1996) (62)
Cholinergic neurons: effect of acute septal lesion on acetylcholine and choline content of rat hippocampus. (1973) (62)
Intracerebroventricular CART peptide reduces rat ingestive behavior and alters licking microstructure. (2001) (62)
Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue. (1984) (62)
Regulation of Neurotransmitter Reuptake by Nitric Oxide (1994) (61)
Cholinergic Neurons: Septal-Hippocampal Relationships (1975) (58)
CART peptide‐immunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat (2001) (58)
Differential regulation of corticotropin-releasing factor receptors in anterior and intermediate lobes of pituitary and in brain following adrenalectomy in rats (1985) (57)
Corticotropin-releasing factor receptors in the pituitary gland and central nervous system: methods and overview. (1986) (56)
Neuroanatomical substrates of anxiety: a brief survey (1986) (56)
Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats (2008) (56)
Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter. (1992) (55)
Cocaine receptors: In vivo labeling with 3H‐(—)cocaine, 3H‐win 35,065‐2, and 3H‐win 35,428 (1989) (55)
Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research. (1993) (55)
Analgesics : neurochemical, behavioral, and clinical perspectives (1984) (55)
Cocaine- and amphetamine-regulated transcript peptide in the rat anterior pituitary gland is localized in gonadotrophs and suppresses prolactin secretion. (2004) (54)
2 beta-substituted analogues of cocaine. Synthesis and inhibition of binding to the cocaine receptor. (1992) (54)
In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428. (1991) (54)
Separation of synaptosomes storing catecholamines and gamma-aminobutyric acid in rat corpus striatum. (1970) (53)
Cocaine- and amphetamine-regulated transcript peptide levels in blood exhibit a diurnal rhythm: regulation by glucocorticoids. (2004) (52)
Enkephalin and neurotensin: immunohistochemical localization and identification of an amygdalofugal pathway. (1978) (52)
Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens (1992) (51)
CART peptide stimulation of G protein-mediated signaling in differentiated PC12 Cells: Identification of PACAP 6–38 as a CART receptor antagonist (2011) (50)
Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]. (1996) (50)
Cocaine-Amphetamine-Regulated Transcript Expression in the Rat Nucleus Accumbens Is Regulated by Adenylyl Cyclase and the Cyclic Adenosine 5′-Monophosphate/Protein Kinase A Second Messenger System (2006) (49)
The effects of cocaine on CART expression in the rat nucleus accumbens: a possible role for corticosterone. (2005) (49)
The effect of adrenalectomy on cocaine and amphetamine-regulated transcript (CART) expression in the hypothalamic nuclei of the rat (2001) (48)
Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: In vivo studies with [125i]rti‐55 (1994) (48)
CART peptide immunoreactivity in the hypothalamus and pituitary in monkeys: Analysis of ultrastructural features and synaptic connections in the paraventricular nucleus (2000) (48)
Muscarinic cholinergic receptor localization in brain by electron microscopic autoradiography (1981) (48)
Dopamine transporter: deglycosylation with exo- and endoglycosidases (1991) (48)
Synthesis and nicotinic acetylcholine receptor binding properties of exo-2-(2'-fluoro-5'-pyridinyl)-7-azabicyclo-[2.2.1]heptane: a new positron emission tomography ligand for nicotinic receptors. (1997) (48)
Benzodiazepine receptors in rat brain are altered by adrenalectomy (1986) (47)
The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans. (2006) (47)
Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens (1996) (46)
CART peptides colocalize with tyrosine hydroxylase neurons in rat locus coeruleus (1999) (46)
Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity. (1999) (46)
Studies of selected phenyltropanes at monoamine transporters. (1999) (46)
Characterization of muscarinic cholinergic receptor binding in the vas deferens, bladder, prostate and penis of the rabbit. (1984) (46)
Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. (2000) (45)
Rate of binding of various inhibitors at the dopamine transporter in vivo (1995) (45)
Action of hemicholinium-3 on cholinergic nerve terminals after alteration of neuronal impulse flow. (1974) (45)
Cocaine displaces [3H]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909. (1991) (44)
Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report. (1985) (44)
Dopamine receptors in the rat frontal cortex: An autoradiographic study (1979) (43)
CART Peptides: Modulators of Mesolimbic Dopamine, Feeding, and Stress (2004) (43)
Expression of a single dopamine transporter cDNA can confer two cocaine binding sites (1992) (43)
N‐substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter (1997) (43)
Activity of various CART peptides in changing locomotor activity in the rat (2002) (42)
Selective accumulation of 3 H-serotonin by nerve terminals of raphe neurones: an autoradiographic study. (1973) (42)
Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors (2006) (42)
Selective dopamine transporter inhibition by cocaine analogs. (1992) (41)
Subcellular localization of dopamine beta-hydroxylase and endogenous norepinephrine in the rat hypothalamus. (1974) (41)
Effects of adrenalectomy on CART expression in the rat arcuate nucleus (2003) (41)
Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76 (2000) (41)
Assessment of dopamine receptor densities in the human brain with carbon‐11‐labeled N‐methylspiperone (1984) (41)
Transcriptional regulation of the CART promoter in CATH.a cells. (2004) (41)
Effects of dopaminergic drugs and acute medial forebrain bundle lesions on striatal acetylcholine levels. (1975) (40)
Synthesis of catecholamines in the locus coeruleus from 3 H-tyrosine in vivo. (1972) (40)
Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse (2006) (40)
Association of serotonin-binding protein with projections of the midbrain raphe nuclei (1975) (40)
Studies of cocaine- and amphetamine-regulated transcript (CART) knockout mice (2006) (40)
α2-adrenergic are receptors are associated with renal proximal tubules (1980) (40)
Cocaine receptors on dopamine transporters mediate cocaine-reinforced behavior. (1988) (40)
[3H]WIN 35,065–2: A Ligand for Cocaine Receptors in Striatum (1990) (39)
CART (cocaine- and amphetamine-regulated transcript) peptide receptors: specific binding in AtT20 cells. (2005) (39)
GABA, benzodiazepine and histamine-H1 receptors in the guinea pig cerebellum: effects of kainic acid injections studied by autoradiographic methods (1981) (39)
Colocalization of CART peptide with prodynorphin and dopamine D1 receptors in the rat nucleus accumbens (2006) (38)
The subcellular distribution of free H3-glutamic acid in rat cerebral cortical slices. (1970) (38)
Vasoactive intestinal peptide receptor localization in rat forebrain by autoradiography (1985) (38)
Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter. (1991) (36)
Autoradiographic Localization of [3H]Gentamicin in the Proximal Renal Tubules of Mice (1979) (36)
Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters (1996) (36)
Sex differences in the regulation of cocaine and amphetamine‐regulated transcript expression in hypothalamic nuclei of rats by forced swim stress (2007) (35)
Synthesis, Ligand Binding, and Quantitative Structure−Activity Relationship Study of 3β-(4‘-Substituted phenyl)-2β-heterocyclic Tropanes: Evidence for an Electrostatic Interaction at the 2β-Position (1996) (35)
Intrathecal CART (55-102) enhances the spinal analgesic actions of morphine in mice (2004) (35)
Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes. (2004) (35)
Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists (2011) (34)
Autoradiographic localization of opioid receptors in the mammalian retina (1981) (34)
Beta-adrenergic receptors in human trabecular meshwork. Identification and autoradiographic localization. (1987) (34)
Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: An isobolographic analysis (2007) (34)
Species‐ and Brain Region‐Specific Dopamine Transporters: Immunological and Glycosylation Characteristics (1996) (34)
3 Beta-(4-ethyl-3-iodophenyl)nortropane-2 beta-carboxylic acid methyl ester as a high-affinity selective ligand for the serotonin transporter. (1997) (34)
Effects of anesthetics and septal lesions and stimulation on 3H-acetylcholine formation in rat hippocampus. (1976) (33)
Attention-Deficit and Disruptive Behavior Disorders (2014) (33)
Colocalization of CART with substance P but not enkephalin in the rat nucleus accumbens (2005) (33)
Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers. (2004) (33)
RTI‐113 administration reduces cocaine self‐administration at high occupancy of dopamine transporter (1998) (33)
Synthesis and transporter binding properties of 3 beta-(4'-alkyl-, 4'-alkenyl-, and 4'-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters: serotonin transporter selective analogs. (1996) (33)
Genes in drug abuse. (2001) (33)
Immunogold Localization of the Dopamine Transporter: An Ultrastructural Study of the Rat Ventral Tegmental Area (1997) (32)
Highly potent cocaine analogs cause long-lasting increases in locomotor activity. (1996) (32)
Cocaine and amphetamine-regulated transcript-containing neurons in the nucleus accumbens project to the ventral pallidum in the rat and may inhibit cocaine-induced locomotion (2010) (31)
CART expression in limbic regions of rat brain following forced swim stress: Sex differences (2006) (31)
CART peptide inhibits locomotor activity induced by simultaneous stimulation of D1 and D2 receptors, but not by stimulation of individual dopamine receptors (2011) (31)
Autoradiographic localization of β-adrenoceptors in rat kidney (1983) (31)
A cocaine-and-amphetamine-regulated-transcript peptide projection from the lateral hypothalamus to the ventral tegmental area (2005) (31)
Forced swim stress elicits region-specific changes in CART expression in the stress axis and stress regulatory brain areas (2012) (31)
Synthesis of [18F]norchlorofluoroepibatidine and its N-methyl derivative: new PET ligands for mapping nicotinic acetylcholine receptors (1997) (30)
In vitro labeling receptor autoradiography: loss of label during ethanol dehydration and preparative procedures. (1982) (29)
Regulation of CART peptide expression by CREB in the rat nucleus accumbens in vivo (2009) (29)
CART receptor binding in primary cell cultures of the rat nucleus accumbens (2008) (29)
CART promoter CRE site binds phosphorylated CREB. (2002) (29)
Autoradiographic localization of 5-HT1 receptors to human and canine basilar arteries (1984) (29)
Development of imaging agents for the dopamine transporter (1995) (28)
Parkinsonian patients report blunted subjective effects of methylphenidate. (1998) (28)
Autoradiographic differentiation of multiple benzodiazepine receptors by detergent solubilization and pharmacologic specificity (1983) (28)
Recent biochemical studies of the dopamine transporter--a CNS drug target. (1998) (28)
Withdrawal from Repeated Cocaine Alters Dopamine Transporter Protein Turnover in the Rat Striatum (2003) (28)
CART-peptide immunoreactivity in enteric nerves in patients with Hirschsprung's disease. (2007) (27)
Amino acid transport: alterations due to synaptosomal depolarization. (1978) (27)
Dopamine transporter imaging with novel, selective cocaine analogs. (1992) (27)
Inhibition of high affinity choline uptake. Structure activity studies. (1980) (27)
Recognition of Dopamine Transporters by Antipeptide Antibodies (1993) (27)
Intrathecal CART (55–102) attenuates hyperlagesia and allodynia in a mouse model of neuropathic but not inflammatory pain (2006) (26)
CART peptide diurnal rhythm in brain and effect of fasting (2005) (26)
Development of PET/SPECT ligands for the serotonin transporter. (1994) (26)
Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain. (1989) (26)
Wake promoting effects of cocaine and amphetamine-regulated transcript (CART) (2010) (25)
In ethanol (1982) (25)
CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion (2016) (25)
Cocaine administration increases the fraction of CART cells in the rat nucleus accumbens that co-immunostain for c-Fos (2008) (25)
Biosynthesis of Catecholamines (1999) (24)
Acetylcholinesterase-staining synaptosomes from rat hippocampus: relative frequency and tentative estimation of internal concentration of free or 'labile bound' acetylcholine. (1974) (24)
Dopamine transporter changes in neuropsychiatric disorders. (1998) (24)
Antinociceptive effects of supraspinal rat cart (55–102) peptide in mice (2003) (23)
Serotonin transporter production and degradation rates: studies with RTI-76 (1999) (23)
Neurotransmitter-specific synaptosomes in rat corpus striatum: morphological variations. (1971) (23)
Effect of gamma-hydroxybutyrate and gamma-butyrolactone on dopamine synthesis and uptake by rat striatum. (1972) (23)
In vivo labeling of neuronal nicotinic acetylcholine receptors with radiolabeled isomers of norchloroepibatidine (1995) (22)
NEUROTRANSMITTER TRANSPORTERS AS DRUG TARGETS : RECENT RESEARCH WITH A FOCUS ON THE DOPAMINE TRANSPORTER (1993) (22)
Use of Single Unit Recording in Correlating Transmitter Turnover with Impulse Flow in Monoamine Neurons (1973) (22)
Atlas of Dopamine Receptor Images (PET) of the Human Brain (1985) (22)
Modulation of the lethal effects of cocaine by cholinomimetics. (1989) (21)
Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3β-(4-[125I]iodophenyl) tropan-2β-carboxylic acid isopropyl ester ([125I]RTM-21) (1996) (21)
Histochemical localization of opiate receptors and opioid peptides. (1978) (21)
Species differences in brain distribution of CART mRNA and CART peptide between prairie and meadow voles (2005) (21)
Chronic Lithium Treatment Decreases Neuronal Activity in the Nucleus Accumbens and Cingulate Cortex of the Rat (1999) (20)
Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. (1996) (20)
Dopamine transport: pharmacological distinction between the synaptic membrane and the vesicular transporter in rat striatum. (1992) (20)
Slow onset of CNS drugs: can changes in protein concentration account for the delay? (2001) (20)
Co-localization of cart peptide immunoreactivity and nitric oxide synthase activity in rat hypothalamus (2000) (20)
Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter. (1996) (20)
STUDIES OF CHOLINERGIC-MONOAMINERGIC INTERACTIONS IN RAT BRAIN* (1978) (20)
Locomotor stimulant effects of novel phenyltropanes in the mouse. (2001) (19)
Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration. (2006) (19)
Receptors for clonidine in brain: insights into therapeutic actions. (1982) (19)
The effects of drug abuse on the human nervous system (2014) (19)
CART Peptides and Drugs of Abuse: A Review of Recent Progress (2016) (19)
OPIATE RECEPTORS: SOME ANATOMICAL AND PHYSIOLOGICAL ASPECTS (1978) (19)
Comparative features of enkephalin and neurotensin in the mammalian central nervous system (1978) (19)
Dopamine Transporter Ligand Binding Domains STRUCTURAL AND FUNCTIONAL PROPERTIES REVEALED BY LIMITED PROTEOLYSIS* (1996) (18)
NEUROTRANSMITTER UPTAKE: A TOOL IN IDENTIFYING NEUROTRANSMITTER-SPECIFIC PATHWAYS (1975) (18)
Brain histamine alterations after hypothalamic isolation. (1974) (18)
Noradrenergic al and a2 receptors: Light microscopic autoradiographic localization (18)
Erratum: Intracerebroventricular CART peptide reduces rat ingestive behavior and alters licking microstructure (American Journal of Physiology - Regulatory, Integrative and parative Physiology (2001) (R1613-R1619)) (2001) (18)
Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions. (1980) (18)
3α-(4‘-Substituted phenyl)tropane- 2β-carboxylic Acid Methyl Esters: Novel Ligands with High Affinity and Selectivity at the Dopamine Transporter (1996) (17)
A cocaine analog and a GBR analog label the same protein in rat striatal membranes (1992) (17)
Developing and Communicating Responsible Data Management Policies to Trainees and Colleagues (2010) (16)
Corticotropin-releasing factor receptors: autoradiographic identification. (1986) (16)
Dopamine transporter: Solubilization from dog caudate nucleus (1989) (16)
Effect of corticosterone on CART peptide levels in rat blood (2005) (16)
Long‐lasting inhibition of in vivo cocaine binding to dopamine transporters by 3β‐(4‐Iodophenyl)Tropane‐2‐Carboxylic acid Methyl Ester: RTI‐55 or βCIT (1995) (16)
CART peptide levels are altered by a mutation associated with obesity at codon 34 (2004) (16)
Unique responses of midbrain CART neurons in macaques to ovarian steroids (2008) (16)
The antagonistic effect of oxytocin and relaxin on rat uterine segment contractility. (1989) (15)
Intra-accumbal administration of shRNAs against CART peptides cause increases in body weight and cocaine-induced locomotor activity in rats (2012) (15)
Neuropeptide receptors in the CNS (1992) (15)
Autoradiograhic localization of the opiate receptor in rat brain. (1975) (15)
Localization of Drug and Neurotransmitter Receptors in Brain by Light Microscopic Autoradiography (1982) (15)
Dopamine receptors in the anterior lobe of the human pituitary gland: autoradiographic localization (1984) (15)
Receptor mapping in neuropharmacology by autoradiography: some technical problems. (1985) (15)
SEROTONIN UPTAKE SYSTEMS IN BRAIN TISSUE (1973) (15)
Autoradiographic localization of [3H]reserpine binding sites in rat brain. (1977) (14)
Neurotransmitter receptors in amyotrophic lateral sclerosis: Possible relationship to sparing of eye movements (1985) (14)
Mapping receptors for alpha 2-agonists in the central nervous system. (1984) (14)
Characteristics and Significance of Sodium-Dependent, High Affinity Choline Uptake (1978) (14)
Recent progress in receptor mapping: Which neurons contain the receptors? (1987) (14)
Synthesis and Monoamine Transporter Binding Properties of 3β-(3‘,4‘-Disubstituted phenyl)tropane-2β-carboxylic Acid Methyl Esters (2005) (14)
Molecular Mechanisms Associated with Cocaine Effects (1992) (14)
Axonal transport of α-bungarotoxin binding sites in rat sciatic nerve (1985) (14)
Cocaine Addiction: Theory, Research and Treatment (1998) (13)
High dose CART peptide induces abnormal EEG activity and behavioral seizures (2008) (13)
Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compounds. (2005) (13)
Erratum: CART peptides: regulators of body weight, reward and other functions (2010) (13)
Quantitative receptor autoradiography: an overview (1986) (13)
Pathways of Addiction: Opportunities in Drug Abuse Research (1998) (12)
Contributions of basic science to understanding addiction (2010) (12)
[125]I-spectramide: a novel benzamide displaying potent and selective effects at the D2 dopamine receptor. (1989) (12)
Neuropeptides in the CNS (1990) (12)
Cocaine self‐administration alters brain NADH dehydrogenase mRNA levels (1997) (12)
In vitro autoradiography. (2001) (12)
Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes. (2007) (11)
Region- and sex-specific changes in CART mRNA in rat hypothalamic nuclei induced by forced swim stress (2012) (11)
[125I]3b-(4-Iodophenyl)tropan-2b-carboxylic Acid Methyl Ester (RTI-55), A Unique Cocaine Receptor Ligand for Imaging the Dopamine and Serotonin Transporters in Vivo (1990) (11)
Synthesis and ligand binding of tropane ring analogues of paroxetine. (1998) (11)
Regulation of cocaine- and amphetamine-regulated transcript mRNA expression by calcium-mediated signaling in GH3 cells (2009) (11)
Histochemical localization of opiate receptors and the enkephalins. (1979) (11)
Synthesis and ligand binding study of 3 beta-(4'-substituted phenyl)-2 beta-(heterocyclic)tropanes. (1995) (11)
Chromatin immunoprecipitation assays revealed CREB and serine 133 phospho-CREB binding to the CART gene proximal promoter (2010) (11)
Potent cocaine analogs inhibit [3H]dopamine uptake in rat mesencephalic cells in primary cultures: pharmacological selectivity of embryonic cocaine sites. (1993) (11)
RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, as a tool for irreversibly inactivating dopamine transporter function in vitro (2000) (10)
Cocaine-and-Amphetamine Regulated Transcript (CART) peptide attenuates dopamine- and cocaine-mediated locomotor activity in both male and female rats: Lack of sex differences (2014) (10)
The inhibition of cocaine-induced locomotor activity by CART 55-102 is lost after repeated cocaine administration (2013) (10)
Displacement of RTI-55 from the dopamine transporter by cocaine. (1996) (10)
CART deficiency increases body weight but does not alter bone strength. (2008) (10)
Histochemical localization of the enkephalins (1979) (10)
Cocaine binding sites related to drug self-administration. (1989) (10)
Neuroimaging and neuropathology. (1988) (9)
Neurotransmitter transporters synthesis and degradation rates. (2001) (9)
Imaging neuroreceptors in the human brain in health and disease. (1985) (9)
Intraperitoneal Administration of CART 55-102 Inhibits Psychostimulant-Induced Locomotion. (2012) (9)
Localization of dopamine transporter protein by microscopic histochemistry. (1998) (8)
Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter. (2002) (8)
Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes. (1999) (8)
On Blacklisting in Science (2008) (8)
Drug addiction : research frontiers and treatment advances (2008) (8)
[3H]Nitrendipine Binding to Calcium Channels in Bovine and Rat Pituitary (1985) (8)
3α-(4-Substituted phenyl)nortropane-2β-carboxylic acid methyl esters show selective binding at the norepinephrine transporter (2000) (7)
CAFFEINE POTENTIATES BOTH ACQUISITION AND MAINTENANCE OF INTRAVENOUS NICOTINE SELF-ADMINISTRATION (1996) (7)
CART peptide: central mediator of leptin-induced adipose tissue apoptosis? (2004) (7)
Pharmacological Aspects of Drug Dependence (1996) (7)
Synthesis, Ligand Binding, and Quantitative Structure-Activity Relationship Study of 3β-(4′-Substituted phenyl)-2β- heterocyclic Tropanes: Evidence for an Electrostatic Interaction at the 2β-Position. (1996) (7)
Social rank and vulnerability to drug abuse (2002) (7)
Collegial Ethics: Supporting Our Colleagues (2012) (7)
Synthesis and Ligand Binding of 3b-(3-Substituted Phenyl)- and 3b-(3,4-Disubstituted Phenyl)Tropane-2b-Carboxylic Acid Methyl Esters (1990) (7)
Phencyclidine binding to striatal cocaine receptors (1990) (7)
Synthesis and Ligand Binding Study of 3β-(4′-Substituted phenyl)- 2β-(heterocyclic)tropanes. (1995) (7)
CART peptide in the nucleus accumbens regulates psychostimulants: Correlations between psychostimulant and CART peptide effects (2017) (7)
RTI-76, an irreversible inhibitor of dopamine transporter binding, increases locomotor activity in the rat at high doses (2001) (7)
Synthesis and receptor binding of cocaine analogs. (1990) (7)
A rapid binding assay for solubilized dopamine transporters using [3H]WIN 35,428 (1991) (6)
Blacklisting among scientists (2009) (6)
Synthesis and transporter binding properties of 2,3-diphenyltropane stereoisomers. Comparison to 3beta-phenyltropane-2beta-carboxylic acid esters. (1997) (6)
On the Use of Protein Turnover and Half-Lives (2009) (6)
Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121). (1996) (6)
Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes. (2005) (6)
α- and β-Adrenergic Receptors (1999) (6)
Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement product. (2005) (6)
Is the Onset of Psychoactive Drug Effects Compatible with a Protein-Synthesis Mechanism? (2003) (5)
3b-(4'-Chlorophenyl)tropan-2b-carboxamides and Cocaine Amide Analogues: New High Affinity and Selective Compounds for the Dopamine Transporter (1992) (5)
Storage and Release of Catecholamines (1999) (5)
Axonal transport of receptors (1984) (5)
Synthesis and cocaine receptor affinities of 3-phenyl-2-(3′-methyl-1,2,4-oxadiazole-5′-yl)tropane isomers (1993) (5)
Measuring levels of proteins by various technologies: can we learn more by measuring turnover? (2010) (5)
Effects of drugs and axotomy on acetylcholine levels in central cholinergic neurons (2004) (5)
Sodium dependent high affinity choline uptake as a regulatory step in acetyl choline synthesis (1975) (5)
Serotonergic synaptosomes from rat hippocampus: lack of acetylcholinesterase (1975) (5)
Turnover of Rat Dopamine Transporter Protein in rDAT-LLC-PK1 Cells (1997) (5)
Collegial ethics: what, why and how. (2011) (5)
Imaging receptors for drugs in neural tissue (1987) (5)
Synthesis of the isomers of (1R)-3-(phenylthio)tropane-2-carboxylic acid methyl ester. A new class of ligands for the dopamine transporter (1997) (4)
Synthesis and transporter binding properties of ( R)-2 ,3 - and ( R)-2 a,3 a-diaryltropanes (1998) (4)
Response: human brain receptor distribution. (1986) (4)
OPIOID RECEPTOR AUTORADIOGRAPHY IN BRAINS OF HUMANS AND ANIMALS (1980) (4)
Radiohistochemical localization of GABA receptors (1980) (4)
Phosphorylation of dopamine transporters and rapid adaptation to cocaine. (1998) (4)
CART Peptide Regulates Psychostimulant-Induced Activity and Exhibits a Rate Dependency. (2017) (4)
Anticocaine catalytic antibodies have no affinity for RTI compounds: Implications for treatment (2001) (4)
Modeling the onset of drug dependence: a consideration of the requirement for protein synthesis. (2006) (3)
Synthesis and monoamine transporter binding properties of 3beta-(3',4'-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters. (2005) (3)
Molecular mechanisms associated with cocaine effects. Possible relationships with effects of ethanol. (1992) (3)
Imaging Transporters for Dopamine and Other Neurotransmitters in Brain (1997) (3)
Synthesis of a radiotracer for studying serotonin-2 receptors: Carbon-11 labeled N-methylketanserin (1989) (3)
Imaging opiate receptors with positron emission tomography (1984) (3)
Serotonin neurons: a synaptic mechanism for the reuptake of serotonin. (1974) (3)
Dopamine Transporter — Cocaine Receptor: Characterization and Purification (1991) (3)
AUTORADIOGRAPHIC LOCALIZATION OF DOPAMINE AND NEUROLEPTIC RECEPTORS IN THE RAT BRAIN USING 3H-SPIPERONE (1979) (3)
In vivo PET and SPECT receptor imaging: new technology and tactics for receptor measurement. (1988) (3)
Nootropics (1993) (3)
Muscarinic Cholinergic Receptor Localization by Radiohistochemistry (1981) (3)
Synthesis and transporter binding properties of (R)-2 beta, 3 beta- and (R)-2 alpha, 3 alpha-diaryltropanes. (1998) (2)
Affective State (2020) (2)
Synthesis of 3β‐(4‐[125I]iodophenyl)tropane‐2‐β‐pyrrolidine carboxamide ([125I]RTI‐229) (1999) (2)
3 alpha-(substituted phenyl)tropane-2 beta-carboxylic acid esters: Ligands with unexpectedly high affinity and selectivity at the dopamine transporter (1996) (2)
Synthesis of [3H]win 35,065-2; A new radioligand for cocaine receptors (1990) (2)
Nicotine Dependence and Its Treatment (2010) (2)
Preface (New Research Frontiers and Advances in Drug Addiction) (2011) (2)
The effects of age on dopamine receptors measured by positron tomography in the living human brain (1984) (2)
Integrative neurobehavioral pharmacology : Focus on cocaine (1996) (2)
Letter from the Editor-in-Chief: Irreproducible Results (2015) (2)
CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants. (2011) (2)
The benzodiazepine receptor: anatomical aspects. (1980) (2)
A GABA transporter cDNA has been cloned (1990) (2)
Synthesis of [125I]‐3β‐(4‐ethyl‐3‐iodophenyl)nortropane‐2β‐carboxylic acid methyl ester ([125I]EINT) (2000) (2)
[125 I]3β‐(4‐ethyl‐3‐iodophenyl)nortropane‐2β‐carboxylic acid methyl ester ([125I]EINT): A potent and selective radioligand for the brain serotonin transporter (2001) (2)
Should Codes of Ethics include expectations of others? (2006) (1)
In vivo labeling of cocaine receptors with sup 3 H-(-) cocaine, sup 3 H-WIN 35,065-2 and sup 3 H-WIN 35,428 (1990) (1)
Muscarinic cholinergic receptor binding in mammalian central and peripheral nervous system: demonstration in vitro and in vivo (1974) (1)
Synthesis, ligand binding, and quantitative structure-activity relationship study of 3 beta-(4'-substituted phenyl)-2 beta-heterocyclic tropanes: evidence for an electrostatic interaction at the 2 beta-position. (1996) (1)
Synthesis and pharmacology of potential site-specific cocaine abuse treatment agents: The role of the phenyl group in 2-substituted-6-aminobicyclo[2.2.2]octanes (2002) (1)
Cocaine receptor: a structure-activity relationship study. (1993) (1)
Commentary Genes in drug abuse (2001) (1)
Autoradiographic Imaging: Localization of Binding Sites other than Neurotransmitter Receptors (1989) (1)
Attention Deficit Hyperactivity Disorders: Animal Models (2014) (1)
3alpha-(4-Substituted phenyl)nortropane-2beta-carboxylic acid methyl esters show selective binding at the norepinephrine transporter. (2000) (1)
PET studies of [18F]norchlorofluoroepibatidine in mapping nicotinic acetylcholine receptors (nAChR) (1996) (1)
Pharmacophore development of (−)-cocaine analogs for the dopamine, serotonin, and norepinephrine uptake sites using a QSAR and CoMFA approach (1993) (1)
Dopamine Transport: Pharmacological Distinction Between the Synaptic Membrane and Vesicular Transporter (1991) (1)
EFFECT OF AGE ON DOPAMINE RECEPTORS IN THE HUMAN BRAIN (1984) (1)
Dopamine Transporter: Function and Imaging (1997) (1)
Synthesis and Nicotinic Acetylcholine Receptor Binding Properties of exo‐2‐(2′‐Fluoro‐5′‐pyridinyl)‐7‐azabicyclo(2.2.1)heptane: A New Positron Emission Tomography Ligand for Nicotinic Receptors. (1997) (1)
The dopamine transporter: binding by the irreversible ligands meta- and para-isothiocyanatobenzoylecgonine methyl ester (1990) (1)
Chapter 1 – Perspectives on Receptor Autoradiography in Human Brain (1991) (1)
Pharmacological Characterization of Axonally Transported [125I]-α-Bungarotoxin Binding Sites in Rat Sciatic Nerve (1986) (1)
Affinity Labeling of Membrane Receptors Using Tissue-Penetrating Radiations (2013) (1)
Comprar Handbook of Contemporary Neuropharmacology, 3 Volume Set | Phil Skolnick | 9780471660538 | Wiley (2007) (1)
Commentary: GPR160 De-Orphanization Reveals Critical Roles in Neuropathic Pain in Rodents (Finally, a Receptor for CART Peptide) (2021) (1)
Radiohistochemical studies of the GABA and beiizodiazepine (BZ) receptors (1979) (1)
What is an animal model ? (2005) (0)
COMPUTER IMAGE ANALYSIS IN NEURODEGENERATIVE DISORDERS: 58 (1982) (0)
a World Health Organization Collaborating Center News and Views (1995) (0)
Receptor binding ligands cocaine. (1992) (0)
Correction: Immunogold localization of the dopamine transporter: An ultrastructural study of the rat ventral tegmental area (1997) (0)
3[beta]-(substituted phenyl)tropan-2-carboxylic acid ester analogues of cocaine: synthesis and biochemical and pharmacological properties (1992) (0)
2013 Daniel H. Efron Research Award (2012) (0)
Synthesis of 3-beta-(4-[125I]Iodophenyl)tropane-2-beta-pyrrolidine Carboxamide ([125I]RTI-229): (1999) (0)
Repetitive Behavior (2021) (0)
3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter. (1996) (0)
Cholinergic Muscarinic Receptor : Biochemical and Light Autoradiographic Localization in the Brain (2018) (0)
PREFACE (2011) (0)
Comprar Annals of the New York Academy of Sciences, Drug Addiction: Research Frontiers | Syed F. Ali | 9781573317184 | Wiley (2008) (0)
5 – ENKEPHALIN DYNAMICS AND NEURONAL LOCALIZATION (1978) (0)
DOPAMINE TRANSPORTER AS A COCAINE RECEPTOR: RECENT IMAGING AND MOLECULAR STUDIES (1992) (0)
Letter from the Editor-in-Chief: Irreproducible Results and NIH Actions (2016) (0)
NEUROPATHOLOGICAL FINDINGS IN THE ACETYLCHOLINERGIC SYSTEM IN ALZHEIMERʼS DISEASE AND SENILE DEMENTIA OF THE ALZHEIMERʼS TYPE (1984) (0)
Mapping Receptors for α2‐Agonists in the Central Nervous System (1984) (0)
Dynamics of Catecholamine Receptors (1999) (0)
Imaging neurotransmitter uptake sites in brain (1992) (0)
219 – THE EFFECT OF CHOLINERGIC DRUGS ON THE ACETYLCHOLINE CONCENTRATION OF THE HIPPOCAMPUS OF RATS (1977) (0)
Synthesis of [I-125]-3 beta-(4-ethyl-3-iodophenyl)nortropane-2 beta-carboxylic acid methyl ester ([I-125]EINT) (1999) (0)
Emerging Technologies and New Directions in Drug Abuse Research : (NIDA Research Monograph ; 112) (1991) (0)
CREB regulation of the CART gene in the rat nucleus accumbens and GH3 cultured cells (2010) (0)
CART peptide may be an endogenous antidepressant (2010) (0)
Synthesis of the Isomers of (1R)-3-(Phenylthio)tropane-2-carboxylic Acid Methyl Ester. A New Class of Ligands for the Dopamine Transporter. (1997) (0)
Recent progress in dopamine transporter research (1994) (0)
24 CHANGES OF MOTOR NEURON CHOLINERGIC RECEPTORS AFTER AXOTOMY (1983) (0)
Prediction of the in vivo pharmacokinetics of binding to CNS opiate receptors from parameters measured in vitro (1982) (0)
Synthesis and Transporter Binding Properties of (R)-2β,3β- and (R)-2α,3α-Diaryltropanes. (1999) (0)
Identification in vivo of muscarinic cholinergic receptor binding in rat brain (1974) (0)
NREM Sleep (0)
CENTRAL AND PERIPHERAL CCK RECEPTORS (1984) (0)
Synthesis of 3 beta-(4-[I-125]Iodophenyl)tropane-2 beta-pyrrolidine carboxamide ([I-125]RTI-229) (1998) (0)
Commentary: GPR160 De-Orphanization Reveals Critical Roles in Neuropathic Pain in Rodents (Finally, a Receptor for CART Peptide) (2021) (0)
CART Peptide and Ingestive Behavior (2006) (0)
Opiate receptor: autoradiographic localization in rat brain C.B. Pert, M.J. Kuhar and S.H. Snyder, Proc. nat. Acad. Sci. (Wash.), 73 (1976) 3729–3733 (1977) (0)
Collegial Ethics: Supporting Our Colleagues (2012) (0)
Localizing Drug and Neurotransmitter Receptors in Vivo with Tritium-Labeled Tracers (2019) (0)
Activities of Daily Living (2021) (0)
RTI‐352: A 3α analogue of RTI‐55 as an in vivo dopamine transporter binding ligand (1997) (0)
Synthesis of [125I]-3-beta-(4-Ethyl-3-iodophenyl)nortropane-2-beta-carboxylic Acid Methyl Ester ([125I]EINT) (2000) (0)
Dopamine D-2 receptor-mediated regulation of central cholinergic activity: PET studies with [F-18]fluoroepibatidine (1997) (0)
Preface (2008) (0)
CART PEPTIDE RECEPTORS: SPECIFIC BINDING IN AtT20 CELLS (2006) (0)
[F-18]norchlorofluorepibatidine (NFED): Preclinical toxicological studies (1996) (0)
RECENT PROGRESS IN TRANSPORTER RESEARCH (1997) (0)
CART peptides in drug abuse and dependence (2003) (0)
Introductory note (2006) (0)
Proceedings: Effect of drugs on alterations of neuronal impulse flow of a central cholinergic tract. (1975) (0)
Anatomy of Catecholaminergic Systems (1999) (0)
Synthesis and Cocaine Receptor Affinities of 3‐Phenyl‐2‐(3′‐methyl‐1,2, 4‐oxadiazole‐5′‐yl)tropane Isomers. (1993) (0)
CART (CART Peptides) (2002) (0)
SODIUM-DEPENDENT HIGH AFFINITY CHOLINE UPTAKE: ITS SIGNIFICANCE AND PRACTICAL USE (1978) (0)
3 beta-phenyl-2 beta-substituted tropanes - An SAR analysis (1997) (0)

This paper list is powered by the following services:

Other Resources About Michael J. Kuhar

What Schools Are Affiliated With Michael J. Kuhar?

Michael J. Kuhar is affiliated with the following schools: